Beauty-from-within (ingestible beauty) supplements are governed by two independent constraints: what the human clinical evidence supports, and what claims law permits. On the evidence, oral collagen peptides, hyaluronic acid, and some carotenoids show measurable effects on skin hydration, elasticity, and photoprotection in randomized controlled trials (RCTs), but most trials are small, short, and industry-funded, and the strongest 2025 collagen meta-analysis found the benefit disappears in independent, high-quality studies. Biotin has little evidence outside deficiency and can distort laboratory tests. On claims, the two major markets diverge. In the United States, structure/function claims such as “supports normal skin” are permitted with a mandatory Food and Drug Administration (FDA) disclaimer, while disease claims are prohibited and the Federal Trade Commission (FTC) expects randomized human trials. In the European Union, only health claims on the official Register may be used, and collagen, hyaluronic acid, and astaxanthin carry none, so on-pack beauty claims are possible only through the authorized claims of accompanying vitamins and minerals.
Content Overview
- How Beauty-From-Within Claims Are Regulated in the US and EU
- Skin Hydration and Elasticity: What the Trials Show
- Photoprotection and Antioxidant Actives
- Hair and Nails: Thin Evidence, Real Safety Limits
- The EU Authorized-Claim Table for Skin, Hair, and Nails
- Permitted Versus Prohibited Claim Language
- Formulation and Dose Implications
- Frequently Asked Questions
- Key Takeaways
- Sources
How Beauty-From-Within Claims Are Regulated in the US and EU
Beauty-from-within products are ingested, which fixes their regulatory category before any claim is written. Under US law, a swallowed product is a dietary supplement or food, not a cosmetic (cosmetics are applied externally), so its beauty messaging is policed as a supplement claim. The Dietary Supplement Health and Education Act (DSHEA) of 1994 permits structure/function claims that describe how a nutrient affects the structure or function of the body, provided the marketer notifies FDA within 30 days of first marketing and carries the disclaimer: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease” [17]. Disease claims, for example treating acne or eczema, convert the product into an unapproved drug and are prohibited. Advertising is separately governed by the FTC, which requires competent and reliable scientific evidence, and whose 2022 Health Products Compliance Guidance states that substantiation of health benefits will generally need to take the form of randomized, controlled human clinical trials [16].
The EU applies a stricter, list-based system. Regulation (EC) No 1924/2006 prohibits any health claim that is not authorized and entered on the EU Register, and there is no US-style structure/function route [18]. The European Food Safety Authority (EFSA) assesses the science, and the Commission authorizes the permitted wordings, published in Regulation (EU) No 432/2012 [19]. The practical consequence for beauty formulators is decisive: ingested collagen, hyaluronic acid, and astaxanthin have no authorized EU health claim, each having been assessed and recorded as non-authorised [20]. A comparative review of skin nutraceuticals reaches a similar split, that a minority of marketed ingredients carry robust evidence while many do not. In the EU, a beauty product can therefore make an on-pack skin, hair, or nail claim only through the authorized claims of accompanying vitamins and minerals.
See and download our infographic on beauty-from-within ingredients:
Skin Hydration and Elasticity: What the Trials Show
Oral collagen peptides have the largest human evidence base among beauty actives, and it is genuinely mixed. A 2023 meta-analysis of 26 RCTs (1,721 participants, doses mostly 2.5 to 10 g per day for 8 to 12 weeks) reported improved skin hydration (standardized mean difference, SMD, 0.63) and elasticity (SMD 0.72), though with high statistical heterogeneity [1]. The important caveat for claims teams comes from a 2025 meta-analysis of 23 RCTs: the pooled benefit held overall but disappeared in the subgroups of independently funded and high-quality trials, leading the authors to conclude that current evidence does not support collagen supplements for skin aging [2]. Reported effects also depend on peptide absorption, with low-molecular-weight fractions studied at roughly 1 to 10 g per day.
Oral hyaluronic acid has a smaller evidence base that points in a consistent direction. A 12-week double-blind, placebo-controlled RCT in 40 adults found that 120 mg per day improved stratum-corneum hydration and reduced transepidermal water loss (TEWL) and wrinkle scores versus placebo [3]. Effective doses typically cluster around 80 to 200 mg per day.
Oral ceramides, meaning plant-derived glucosylceramides, are the best mechanistic fit for skin barrier support, though the evidence is the thinnest of the three. A 2022 meta-analysis found a modest but significant improvement in hydration (SMD 0.40) and a reduction in TEWL across 11 trials, typically at 0.4 to 30 mg per day of glucosylceramides [4]. None of collagen, hyaluronic acid, or ceramides holds an authorized EU health claim, so their measured effects cannot be stated on an EU label.
Photoprotection and Antioxidant Actives
Astaxanthin, a carotenoid from the microalga Haematococcus pluvialis, is the most-studied antioxidant beauty active, though its trials are small and mostly manufacturer-linked. A 2021 meta-analysis reported improved skin moisture (SMD 0.53) and elasticity (SMD 0.77) but no significant wrinkle effect, at typical doses of 3 to 6 mg per day [5]. In the EU, astaxanthin from Haematococcus pluvialis is an authorized novel food with a supplement intake ceiling of 8 mg per day for adults, and it carries no authorized skin claim [15].
Dietary carotenoids provide the most consistent oral photoprotection signal, but the caution is significant. A meta-analysis found that beta-carotene reduces sunburn susceptibility only after sustained supplementation of at least 10 weeks [6]. The problem is dose overlap with a documented harm: the skin-relevant range, roughly 24 to 30 mg per day, sits near intakes that raised lung-cancer risk in smokers. The Alpha-Tocopherol Beta-Carotene (ATBC) trial in 29,133 male smokers found an 18 percent increase in lung-cancer incidence with 20 mg per day of beta-carotene [7], and EFSA’s 2024 review accordingly advises that smokers avoid beta-carotene supplements [14]. Other carotenoids such as lycopene have been studied for photoprotection, but in smaller trials.
Polyphenol actives are weaker still. Standardized French maritime pine bark extract has improved hydration and elasticity in small, largely open-label studies, and cocoa flavanols reduced wrinkle roughness and improved elasticity in a 24-week RCT at about 320 mg per day [8], although the largest photoprotection trial of cocoa found no effect. The only authorized EU claim for cocoa flavanols is vascular, not cosmetic. Botanical actives studied for skin, such as standardized black ginger, remain at the exploratory stage. None of these antioxidant actives carries an authorized EU skin claim.
Hair and Nails: Thin Evidence, Real Safety Limits
Hair and nail actives have the weakest evidence and the clearest safety flags. Biotin, the default hair-and-nails vitamin, shows benefit mainly in genuine deficiency or specific pathologies, with no controlled evidence in non-deficient people [10]. It also carries a safety concern unrelated to toxicity: FDA warns that biotin interferes with many laboratory immunoassays, including falsely low troponin results that can mask a heart attack, and beauty supplements often contain 5 to 10 mg, far above the roughly 30 micrograms needed daily [13]. Biotin has no authorized EU hair-growth claim, only maintenance of normal hair.
Two better-controlled actives illustrate how modest the effects tend to be. Choline-stabilized orthosilicic acid, a bioavailable form of silicon, increased hair tensile strength and cross-sectional area versus placebo at 10 mg of silicon per day over 9 months in a double-blind RCT [11]. A marine-protein complex increased phototrichogram terminal-hair counts and reduced shedding in women with self-perceived thinning hair, although every identified trial was sponsor-funded [12]. Solubilized keratin combinations report similar improvements but rest on single, small, combination-product trials.
Minerals matter mainly through deficiency and excess, not through loading replete people. Zinc deficiency can cause hair loss, but the tolerable upper intake level is 40 mg per day and chronic excess induces copper deficiency. Selenium is more cautionary, following a U-shaped curve where excess is toxic. A 2008 US outbreak from a mislabeled supplement delivering roughly 200 times the intended selenium, near 41,750 micrograms per day, caused hair loss in about 70 percent and nail changes in about 61 percent of the 201 affected people [9]. The tolerable upper intake level for selenium is 400 micrograms per day. These limits, not growth claims, should drive beauty formulation decisions for minerals.
The EU Authorized-Claim Table for Skin, Hair, and Nails
In the EU, the only compliant on-pack beauty claims attach to specific vitamins and minerals, and only when the product delivers at least a source-of amount, defined as 15 percent of the Nutrient Reference Value (NRV) per portion [19]. The table below gives the authorized wordings that beauty formulations rely on. Vitamin C is the linchpin, because its authorized claim explicitly connects collagen formation to skin.
Table 1. EU authorized health claims relevant to beauty, with the minimum source-of amount to bear the claim (Regulation (EU) No 432/2012).
| Nutrient | Authorized claim wording | Minimum amount to bear the claim |
|---|---|---|
| Vitamin C | “Vitamin C contributes to normal collagen formation for the normal function of skin” | 12 mg |
| Biotin | “Biotin contributes to the maintenance of normal skin” and “normal hair” | 7.5 micrograms |
| Zinc | “Zinc contributes to the maintenance of normal skin, hair, and nails” | 1.5 mg |
| Selenium | “Selenium contributes to the maintenance of normal hair and nails” | 8.25 micrograms |
| Niacin | “Niacin contributes to the maintenance of normal skin” | 2.4 mg |
| Riboflavin | “Riboflavin contributes to the maintenance of normal skin” | 0.21 mg |
| Vitamin A | “Vitamin A contributes to the maintenance of normal skin” | 120 micrograms |
| Copper | “Copper contributes to normal skin and hair pigmentation” | 0.15 mg |
Where a nutrient is authorized for more than one tissue, each tissue is a separate authorized statement that must appear on-pack in its exact wording; the table groups them per nutrient for brevity. Collagen, hyaluronic acid, and keratin appear nowhere on this list, and biotin’s only authorized claim is maintenance, not growth. Beauty botanical supplements face an added complication: roughly 2,000 botanical health claims remain on hold and unassessed, so they carry legal uncertainty rather than validation.
Read our Introduction to Vitamins and Minerals as Supported Nutrients in Nutraceuticals:
Permitted Versus Prohibited Claim Language
The gap between a compliant claim and a violation is narrow and specific. The pattern is consistent across both markets: language that describes maintaining a normal structure or function is generally defensible, while language implying a cure, a disease effect, or a proven dramatic transformation is not. The table below maps common beauty messages to compliant and non-compliant phrasings.
Table 2. Permitted versus prohibited beauty-from-within claim language across the US and EU.
| Intended message | Permitted phrasing | Prohibited phrasing |
|---|---|---|
| General skin health | “Supports healthy, normal skin” | “Reverses wrinkles,” “erases fine lines” |
| Collagen support (EU) | “Vitamin C contributes to normal collagen formation for the normal function of skin” | “Collagen rebuilds your skin” |
| Hydration and elasticity | “Helps maintain skin elasticity and hydration” | “Clinically proven to eliminate cellulite” |
| Blemish-prone skin | Describe normal skin only | “Clinically proven to cure acne” |
| Anti-aging | “Supports the skin’s natural collagen” | “Anti-aging cure,” “turns back the clock” |
| Hair and nails (EU) | “Zinc contributes to the maintenance of normal hair and nails” | “Regrows hair,” “stops hair loss” |
| Antioxidant (EU) | “Vitamin C contributes to the protection of cells from oxidative stress” | “Astaxanthin protects skin from UV damage” |
The recurring failure mode is overstatement, claiming a proven, drug-like effect that neither the evidence nor the claim register supports. Consumer testimonials do not create a workaround, because the FTC holds endorsed claims to the same substantiation standard as claims the company makes directly [16].
Formulation and Dose Implications
For product developers, the evidence and the claim rules translate into concrete constraints. The first is the dose gap: clinically studied doses are often far higher than the token amounts in many marketed products. Collagen studies use 2.5 to 10 g per day, which effectively rules out capsules and pushes formats toward powders, stick packs, and beauty shots, while low-dose actives such as astaxanthin (3 to 6 mg) or choline-stabilized orthosilicic acid (10 mg of silicon) fit capsules and gummies comfortably.
The second constraint is the EU source-of threshold. To carry any authorized skin, hair, or nail claim, a product must deliver at least 15 percent of the NRV of the relevant vitamin or mineral per portion, so a beauty blend seeking a compliant claim should be built around a qualifying dose of vitamin C, zinc, or biotin, not around the unclaimable hero ingredient. Formulating a stable, palatable dose of a nutrient such as vitamin C is itself a technical exercise, given its moisture and heat sensitivity.
The third is stability and safety within the chosen format. Astaxanthin and other carotenoids oxidize and generally need protective encapsulation; wheat-derived ceramides require a gluten allergen declaration; marine-derived actives require a fish or shellfish declaration; and beta-carotene at photoprotective doses warrants a smoker caution. Aligning the studied dose, the claimable nutrient, and the format constraints is the core formulation problem for a credible beauty-from-within product.
Frequently Asked Questions
Does oral collagen actually improve skin? Randomized trials and pooled analyses report improved skin hydration and elasticity at 2.5 to 10 g per day, but the effect is inconsistent. A 2025 meta-analysis found that the benefit disappeared in independently funded, high-quality studies, so the honest position is that collagen may support skin measures while the evidence remains contested and largely industry-generated [2].
Can a beauty supplement be marketed as clinically proven anti-aging? No. Anti-aging framed as a cure or a proven transformation implies a drug-like effect that neither US nor EU rules allow, and “clinically proven” invites strict scrutiny of the underlying trials. Compliant language stays with supporting or maintaining normal skin, and in the EU it must match an authorized claim wording exactly.
Which beauty ingredients can carry an EU health claim? Only vitamins and minerals with authorized wordings, including vitamin C, biotin, zinc, selenium, niacin, riboflavin, vitamin A, and copper, and only when the product provides at least 15 percent of the Nutrient Reference Value per portion. Collagen, hyaluronic acid, keratin, and astaxanthin have no authorized EU claim [19].
Is biotin worth including for hair and nails? Biotin shows benefit mainly in genuine deficiency, which is rare, and no controlled evidence supports it in well-nourished people. It also interferes with laboratory tests, including falsely low troponin, so high doses carry a real clinical caution. It can carry an EU maintenance-of-normal-hair claim, but not a growth claim [13].
Is beta-carotene safe in a beauty supplement? Beta-carotene supports photoprotection only after sustained use at roughly 24 to 30 mg per day, but that range overlaps doses that increased lung-cancer risk in smokers. EFSA advises that smokers avoid beta-carotene supplements, so any product using it at photoprotective doses should carry a clear smoker caution [7,14].
What dose is needed to make an EU beauty claim? The product must be at least a source of the nutrient, defined as 15 percent of the Nutrient Reference Value per portion. For vitamin C that is 12 mg, for zinc 1.5 mg, and for biotin 7.5 micrograms. Below these thresholds, no authorized claim may be made, regardless of the other ingredients present [19].
Key Takeaways
Oral collagen peptides, hyaluronic acid, and some carotenoids show measurable skin effects in RCTs, but most trials are small, short, and industry-funded, and independent high-quality collagen data are weak.
Beta-carotene is the clearest safety flag, because photoprotective doses overlap intakes that raised lung-cancer risk in smokers.
Biotin lacks evidence outside deficiency and can distort laboratory tests, including troponin used to detect heart attacks.
In the EU, collagen, hyaluronic acid, keratin, and astaxanthin have no authorized health claim; only accompanying vitamins and minerals at a 15 percent NRV dose can carry a beauty claim.
In the US, structure/function claims are allowed with the FDA disclaimer, but the FTC expects randomized human trials and holds testimonials to the same standard.
The core formulation problem is aligning the clinically studied dose, the claimable nutrient, and the delivery format.
Sources
- Pu S-Y, et al. Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients, 2023.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10180699/ - Myung S-K, Park Y. Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The American Journal of Medicine, 2025.
https://www.amjmed.com/article/S0002-9343(25)00283-9/abstract - Hsu T-F, et al. Oral Hyaluronan Relieves Wrinkles and Improves Dry Skin: A 12-Week Double-Blinded, Placebo-Controlled Study. Nutrients, 2021.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8308347/ - Sun Q, et al. Effectiveness of Dietary Supplement for Skin Moisturizing in Healthy Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Nutrition, 2022.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9201759/ - Zhou X, et al. Systematic Review and Meta-Analysis on the Effects of Astaxanthin on Human Skin Ageing. Nutrients, 2021.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8472736/ - Köpcke W, Krutmann J. Protection from Sunburn with Beta-Carotene: A Meta-analysis. Photochemistry and Photobiology, 2008.
https://pubmed.ncbi.nlm.nih.gov/18086246/ - The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male Smokers. New England Journal of Medicine, 1994.
https://pubmed.ncbi.nlm.nih.gov/8127329/ - Yoon HS, et al. Cocoa Flavanol Supplementation Influences Skin Conditions of Photo-Aged Women: A 24-Week Double-Blind, Randomized, Controlled Trial. Journal of Nutrition, 2016.
https://pubmed.ncbi.nlm.nih.gov/26581682/ - MacFarquhar JK, et al. Acute Selenium Toxicity Associated With a Dietary Supplement. Archives of Internal Medicine, 2010.
https://pubmed.ncbi.nlm.nih.gov/20142570/ - Patel DP, Swink SM, Castelo-Soccio L. A Review of the Use of Biotin for Hair Loss. Skin Appendage Disorders, 2017.
https://karger.com/sad/article/3/3/166/291279 - Wickett RR, et al. Effect of oral intake of choline-stabilized orthosilicic acid on hair tensile strength and morphology in women with fine hair. Archives of Dermatological Research, 2007.
https://link.springer.com/article/10.1007/s00403-007-0796-z - Ablon G. A 3-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of a Marine Protein Supplement to Promote Hair Growth and Decrease Shedding in Women with Self-Perceived Thinning Hair. Dermatology Research and Practice, 2015.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4389977/ - US Food and Drug Administration. Biotin Interference with Troponin Lab Tests: Assays Subject to Biotin Interference (FDA Safety Communication). 2019.
https://www.fda.gov/medical-devices/in-vitro-diagnostics/biotin-interference-troponin-lab-tests-assays-subject-biotin-interference - EFSA Panel on Nutrition, Novel Foods and Food Allergens. Scientific opinion on the tolerable upper intake level for preformed vitamin A and beta-carotene. EFSA Journal, 2024.
https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2024.8814 - EFSA Panel on Nutrition, Novel Foods and Food Allergens. Safety of astaxanthin for its use as a novel food in food supplements. EFSA Journal, 2020.
https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2020.5993 - US Federal Trade Commission. Health Products Compliance Guidance. 2022.
https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance - US Code of Federal Regulations. 21 CFR 101.93: Certain types of statements for dietary supplements.
https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101/subpart-F/section-101.93 - European Parliament and Council. Regulation (EC) No 1924/2006 on nutrition and health claims made on foods. 2006.
https://eur-lex.europa.eu/eli/reg/2006/1924/oj/eng - European Commission. Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods. 2012.
https://eur-lex.europa.eu/eli/reg/2012/432/oj/eng - European Commission. EU Register of nutrition and health claims made on foods.
https://ec.europa.eu/food/food-feed-portal/screen/health-claims/eu-register
These statements have not been evaluated by the Food and Drug Administration. This information is provided for dietary supplement industry professionals and is not intended to diagnose, treat, cure, or prevent any disease.
Read more on skin health ingredients here:
Collagen as a Nutraceutical Ingredient: Types, Processing, Formulation, and Supplier Landscape
